Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Pushes Champix In India Through Private Hospitals And Clinics As Smoking Epidemic Hits India

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - A smoking epidemic that kills nearly a million people in India every year has led Pfizer to get aggressive on collaborating with private sector healthcare units to open 600 smoking cessation clinics in the next two years
Advertisement

Related Content

Pfizer’s Champix Faces Patent Hurdle In India As Dr Reddy’s Raise Questions
Pfizer’s Champix Faces Patent Hurdle In India As Dr Reddy’s Raise Questions
Pfizer Follows Novartis; Offers To Up Stake In Indian Arm To 75 Percent
Pfizer Follows Novartis; Offers To Up Stake In Indian Arm To 75 Percent
Pfizer Follows Novartis; Offers To Up Stake In Indian Arm To 75 Percent
Pfizer Follows Novartis; Offers To Up Stake In Indian Arm To 75 Percent
Pfizer Plans to Launch Anti-Smoking Chantix in India by End of February
Pfizer Plans to Launch Anti-Smoking Chantix in India by End of February
Advertisement
UsernamePublicRestriction

Register

SC071031

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel